Developer of medical devices designed to improve home patient monitoring. The company's devices aid in the diagnostic evaluation as well as monitoring of therapeutic interventions for multiple medical conditions including trauma, dehydration, and sepsis, enabling physicians to simplify home and critical care, prevent unnecessary acute visits, and improve emergency or critical care.
PneumoNIX Medical is developing gel-based technologies to prevent complications associated with percutaneous procedures such as soft tissue biopsies.
OmniVis operates a portable pathogen detection platform that allows for the rapid and accurate measurement of pathogens in various environments, particularly in food processing facilities. The company provides an easy-to-use hardware device in conjunction with disposable test kits that can analyze swabs or liquid samples. This streamlined process reduces the pathogen detection time to just 30 minutes, making it both efficient and cost-effective for health organizations. By focusing on user-friendly technology, OmniVis aims to enhance the accuracy of pathogen detection while ensuring affordability and simplicity in its application.
Developer of an implantable continuous blood pressure monitoring solution intended for early and accurate detection of dangerous blood pressures that lead to organ damage. The company's device provides advanced notice of changing health status using end-to-end results seamlessly and remotely which connects patients and clinicians through a cloud-based software and analytics platform, enabling timely, cost-effective clinical interventions to intercept and possibly prevent a hypertension crisis.
the first nasal endoscope for primary care
Colabs is a medical device manufacturing company that focuses on developing an emergency airway and ventilation system. Its device specializes in airway management and ventilation during cardiac arrest.
The company was founded in 2012 and headquartered in St, Morgan Hill, California.
Evolution Devices is a bioelectric solution for tracking and improving walking rehabilitation for those affected by neurological impairment. The company is using artificial intelligence technology to transform the standard of care for those affected by neurological walking impairments and re-train their walking through data analytics and targeted stimulation.
Respira Labs, Inc. is a company focused on developing innovative solutions for managing chronic obstructive pulmonary disease (COPD). Based in Mountain View, California, the company has created Sylvee, a wearable device that utilizes advanced technology to continuously monitor lung function and predict COPD exacerbation attacks in real-time. This device is equipped with non-invasive acoustic sensors and employs techniques such as audio signal processing and machine learning to detect "trapped air," an early indicator of potential COPD issues. By enabling early intervention and prevention of exacerbations, Respira Labs aims to enhance patient quality of life and health outcomes while also reducing healthcare costs. Founded in 2018, the company is positioned to transform the landscape of COPD management through its innovative approach.
Relavo, LLC is a medical device company founded in 2018 and based in Baltimore, Maryland. The company focuses on developing solutions to prevent infection related to peritoneal dialysis, specifically through its product, The PeritoneX. This device disinfects contamination points prior to the initiation of dialysis treatment, thereby helping patients with kidney failure to lower their risk of developing peritonitis. By offering an affordable means to enhance safety during peritoneal dialysis, Relavo aims to improve patient outcomes in this critical area of healthcare.
Aqua Science offers a global platform of technologies and fast and reliable solutions for the testing and treatment of water. They provide research and development, custom reagent and kit manufacture, product assembly, lyophilization services, and contract manufacturing services.
Canomiks provides a genomics, bioinformatics and AI-based Product Superiority Platform that enables companies within the functional food and beverage, dietary supplement and skincare industries to create safe and efficacious products. Canomiks' long-term vision is to make food as medicine a reality.
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
Lura Health is a company that specializes in developing tooth-mounted sensors designed to monitor oral health through saliva analysis. Founded in 2016 and based in Cambridge, Massachusetts, Lura Health's wireless intra-oral sensors allow users to continuously track key diagnostic metrics related to their oral environment. The sensors are designed to sit comfortably on a single tooth and monitor oral acidity, transmitting data to a mobile application. This technology provides users with meaningful insights and instant feedback, empowering them to take control of their health and improve personal health management by setting and achieving health goals.
UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.
Developer of chemical detection sensors designed to sample and measure the trace-level concentration of gases in harsh industrial environments. The company's sensors help in calibration-free sensing, have an internal pump, are portable and rugged, and require low power consumption, enabling clients to have laser-based sensing that helps in leak detection and exhaust monitoring.
FuturesTHRIVE develops an AI platform to identify and track pediatric mental health easily. FuturesTHRIVE's platform uses a combination of artificial intelligence, sentiment analysis, and machine learning to provide a mental health baseline that can be used by doctors and families to better understand a child's mental health qualities, thereby helping to identify mental health conditions in children easily and early.
Intelligent Medicine provides software and simulation services in medical, artificial intelligence, and virtual reality simulators. Their solution provides architects and facility stakeholders the ability to test and optimize building designs and protocols, thereby reducing infectious spread probability and user congestion.
PediaMetrix Inc. develops a smart digital tool for pediatric head measurement and monitoring. It offers a flat head syndrome app enables parents to receive accurate measures of their baby's head shape and receive repositioning instructions specific to their baby instantly. The company’s app also enables pediatricians to have access to the data and easy-to-understand analysis of the smart algorithms behind the app to save time and ensure quality care. PediaMetrix Inc. was founded in 2018 and is based in Rockville, Maryland.
TQIntelligence, Inc. owns and operates a platform which measures the severity of the emotional distress. The platform integrates multiple data sources and offers cognitive insights into risk stratification, treatment outcomes tracking, and personalized behavioral health interventions. The company products include TQ-Intelligence, including insights from voice/speech analytics and other psychometrically sound instruments and TQ Analytics which offers solutions using existing EMR data with actionable insights. The company features include machine learning analytics, knowledge graph, and real time prediction. TQIntelligence, Inc. was founded in 2016 and is headquartered in Atlanta, Georgia.
PathOtrak, LLC specializes in developing food safety testing kits that facilitate the rapid detection of pathogens, such as Salmonella and E. coli, in food products. Founded in 2016 and located in College Park, Maryland, the company employs innovative microfiltration technology in its sample-preparation kits to significantly reduce testing time from days to hours. This advancement not only enhances food safety but also allows producers to release products more quickly, improving the balance between shelf life, profitability, and safety in the food industry. PathOtrak's solutions are validated through extensive testing and analysis, addressing the critical needs of various stakeholders involved in ensuring a safe food supply.
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.
Quadralynx specializes in the development of wearable biometric devices tailored for adults experiencing motor speech disorders, particularly those who face challenges with volume control due to Parkinson's disease and similar neurological conditions. The company's innovative device employs biofeedback technology to alert users through vibrations when their voice reaches a pathological state. By focusing on speech and voice improvement, Quadralynx aims to enhance the quality of life for individuals affected by these disorders.
OPOS operates a patient monitoring and opioid prescriber compliance platform designed to assist primary care and pain specialists across various practice settings. The company focuses on ensuring that opioid prescribers adhere to guidelines set by the Centers for Disease Control and Prevention, state authorities, and medical boards. By providing documented evidence of compliance, along with clinical decision support, OPOS enables healthcare providers to enhance patient outcomes and assess individual and collective risks associated with patients, prescribers, and practices. Their services not only promote regulatory compliance but also aim to reduce prescribing risks and administrative overhead, thus generating revenue through improved operational efficiency in opioid treatment.
Spekciton Biosciences specializes in biophotonic measurement systems and services aimed at enhancing agricultural performance and sustainability. The company develops innovative technologies that enable the rapid and precise detection of plant stress and viability, providing farmers with essential insights for improving crop management. Additionally, Spekciton offers biosensors designed to quickly identify soil and water contamination, supporting environmental health and agricultural productivity. Through its advanced measurement solutions, the company contributes to a better understanding of bioprocesses, ultimately aiding in the cultivation of resilient and sustainable crops.
Aracari's 3D Vascularized Micro-Organ platforms are designed to increase the efficiency of the drug discovery pathway by significantly enhancing the biological authenticity of pre-clinical testing platforms.
Medecipher is a highly innovative early stage company providing innovative solutions to help hospitals improve their operations.
Koda Health, Inc. is a Houston-based company that provides a data-driven, video-based interactive platform aimed at enhancing communication between healthcare providers and elderly patients. Founded in 2020, Koda Health focuses on facilitating personalized end-of-life conversations, allowing patients to articulate their healthcare preferences and make informed decisions about their medical care in advance. The platform utilizes artificial intelligence to guide patients through discussions about their quality of life, designating power of attorney, and identifying emergency contacts. By doing so, Koda Health helps ensure that patients' healthcare preferences are respected while simultaneously aiding healthcare systems in reducing unnecessary expenditures. The company also collects valuable data on patient personas and care preferences, enriching the understanding of patient needs in clinical settings.
Clairways specializes in smart lung monitoring technology designed for pharmaceutical clinical trials. The company develops a wearable digital lung monitor that captures critical respiratory metrics for individuals suffering from conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). Fitted to the body, this device employs acoustic sensors and machine learning technology to detect and characterize various respiratory metrics. The collected data is presented in an accessible format, allowing healthcare providers to easily monitor and assess patients' respiratory health over the long term.
STL Scientific develops a non-invasive screening tool for detecting overweight trucks on the road in real-time. The company's headquarters are in Temple City, California.
Biochip Labs, founded in 2019 and headquartered in Cleveland, Ohio, specializes in laboratory testing services for blood disorders, particularly sickle cell disease and thalassemia. The company offers a variety of proprietary microfluidic biomarker assays that assess blood cell adhesion, red blood cell deformability, whole blood rheology, and endothelialized microfluidics. These assays are designed to evaluate the efficacy of emerging targeted and curative therapies, allowing clinicians to effectively monitor patient responses to treatment. By focusing on accurate and high-quality testing, Biochip Labs aims to advance the understanding and management of blood disorders.
Kintsugi utilizes machine learning and voice biomarkers to detect clinical depression and anxiety, providing innovative talk therapy software to users in over 250 cities worldwide. By analyzing short clips of free-form speech, the company has developed a mental healthcare infrastructure that identifies signs of these conditions, thereby assisting medical practitioners in addressing gaps in mental health care. Kintsugi has amassed the world's largest longitudinal, annotated voice data set for this purpose, resulting in the creation of a clinical-grade voice biomarker diagnostic, which is currently pending patent and FDA approval. This technology aims to measure the severity of depression and anxiety in real-time, offering a more effective approach to mental health assessment and intervention.
xMD Diagnostics operates in the healthcare industry focusing on biotechnology business. The company was formerly known as Bay Resources Development Group. The company is headquartered in Annapolis, Maryland. xMD Diagnostics uses high-throughput microdissection technology for the diagnosis of cancer.
Developer of a novel approach augmented low-pass long-read NGS designed to facilitate the detection of complex genetic variation. The company's platform processes long-read ngs raw data DNA sequences, enabling clients to minimize time spent on variant calling and have resolved variants, with a reduction of cost, and improved tat and scalability.
NanoSpy, Inc. was founded in 2017 to establish the new state-of-the-art in rapid pathogen detection. Using proprietary and patent-pending technologies, we leverage our expertise in biomedical engineering, microbiology, nanomaterials, and mechanical engineering to dramatically simplify the detection process with a new paradigm in biosensor platforms. Sensitivity, specificity, and speed now are combined in one convenient test that delivers results fast! In 20 minutes, NanoSpy biosensors can detect a single targeted pathogen at 5 CFU/mL or less from common buffer samples taken right at the point of detection. No time-consuming enrichment process. No environmentally hazardous reagents. No laboratory requirements. Translation: No time wasted. No decisions delayed.
Kodikaz Therapeutic Solutions is focused on advancing cancer treatment by developing targeted therapies aimed at eradicating cancers while minimizing side effects. The company utilizes its innovative Zip-Code™ Technology platform, a first-in-class delivery system that facilitates cell-specific genomic transfer for both RNA and DNA applications. Rooted in discoveries from human cancers, this platform addresses the limitations associated with traditional viral delivery methods, providing a more effective and safer alternative. Kodikaz's research generates valuable in-vitro and in-vivo data across various oncological applications, including pancreatic, myeloma, and colorectal cancers, supporting the development of curative gene transfer technologies.
Empo Health specializes in in-home health monitoring, focusing on early detection of diabetic foot conditions to prevent amputations. The company has developed innovative bathroom scales and a digital health platform that provide reliable visual data for patients and clinicians outside of clinical settings. By integrating these tools into everyday life, Empo Health aims to enhance patient care and contribute to better health outcomes.
Developer of neurodiagnostic technologies intended to commercialize blood testing products. The company provides critical data that can be useful in diagnosis, monitoring and assessing therapeutic responses that help to make discoveries for brain health and diseases, enabling pharmaceutical companies and researchers to drug discovery and conduct studies in brain disease.
KovaDx focuses on improving healthcare access for individuals suffering from Sickle Cell Disease and other hemolytic anemias through an innovative point-of-care solution. The company has developed a health monitoring tool that utilizes Quantitative Phase Imaging and deep learning technology to provide affordable and easy-to-use diagnostics. This system is designed to bridge gaps in care for blood diseases, enabling better management of blood health. By offering a diagnostic and monitoring device, KovaDx aims to enhance the understanding of treatment impacts and improve patient outcomes. Ultimately, the company seeks to support individuals with Sickle Cell Disease in enhancing their overall prognosis and quality of life.
Developer of virus-resistant live bacterial products designed to modulate the human microbiome. The company targets the viral components of the gut microbiome to treat disease and focus on healthy gut bacteria and their predatory phages to engineer resistant strains, and also develops a new class of live biotherapeutics, enabling medical science professionals to specifically target phages or viruses with a specific affinity for inducing lysis.
Respira Labs, Inc. is a company focused on developing innovative solutions for managing chronic obstructive pulmonary disease (COPD). Based in Mountain View, California, the company has created Sylvee, a wearable device that utilizes advanced technology to continuously monitor lung function and predict COPD exacerbation attacks in real-time. This device is equipped with non-invasive acoustic sensors and employs techniques such as audio signal processing and machine learning to detect "trapped air," an early indicator of potential COPD issues. By enabling early intervention and prevention of exacerbations, Respira Labs aims to enhance patient quality of life and health outcomes while also reducing healthcare costs. Founded in 2018, the company is positioned to transform the landscape of COPD management through its innovative approach.
Developer of wearable devices designed to monitor and detect anxiety and stress symptoms. The company's devices incorporate artificial intelligence and machine learning and integrate biometrics for automated, early detection of increasingly stressed states and provide access to therapists for personalized recommendations and progress reviews, enabling users to deepen their understanding of themselves and revolutionize the way they approach mental health.
Frugi Biotechnology is a synthetic biology company based in Ames, Iowa, founded in 2020. The company specializes in developing modular, paper-based diagnostics aimed at managing viral outbreaks. Frugi's services include creating custom cell-free extracts that facilitate the building and testing of learn cycles for clients involved in protein biomanufacturing and protein discovery. This allows clients to detect pathogens in a simplified and cost-effective manner, enhancing the capabilities for outbreak management and response.
Sequitur Health develops a blood biomarker monitoring device with the aim of saving, extending, and improving people's lives. The company was founded in 2019 and is headquartered in Scottsdale, Arizona.
Hermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point of care. The company was founded by Sasank Vemulapati.
HC Simulation, founded in 2011 and headquartered in Canton, Mississippi, focuses on developing advanced products that utilize the HumMod engine to simulate human physiology. The company's offerings allow users to explore physiological interactions that are often difficult to observe through traditional methods. By providing high-quality simulations, HC Simulation aids in the ideation, development, and prediction of innovative medical devices and pharmaceuticals, enhancing the understanding of complex biological systems.
Theromics Inc. develops cell therapies. It offers HeatSYNC Gel, a thermal accelerant (TA) that augments MW and RF energy by increasing local tissue electrical conductivity in a reproducible and effective manner. The company’s TA absorbs microwave energy effectively preventing heat loss caused by blood flow in large vessels adjacent to ablation zone; optimizes the shape of the ablation zone into a circle making the ablation volume predictable; and produces a larger ablation area making it easier to target the tumor center and with 3-D modeling optimizes antenna guidance into tumor mass. Theromics Inc. was founded in 2016 and is based in West Bridgewater, Massachusetts.
LumenAstra, founded in 2020 and headquartered in Longmont, Colorado, develops non-invasive, wearable deep-tissue temperature sensors aimed at enhancing patient care in various medical contexts. The company's innovative technology allows for the external measurement of internal temperature, making it particularly useful in cancer hyperthermia therapy. Additionally, LumenAstra's sensors have applications in monitoring hypothermia during aortic dissection repair, brain temperature in neonatal hypoxia-ischemia cases, and internal heat stress in military and hazardous environments. This technology enables medical professionals to effectively protect patients from serious injuries and fatalities related to heat stress.
BioSense8 develops biosensors for use in human and animal healthcare, and environmental wellness. The company was founded in 2020 and is headquartered in Boston, Massachusetts.
Drive Therapeutics is a biotechnology company focused on enhancing treatments for retinal diseases. The company is developing therapeutics specifically aimed at addressing wet age-related macular degeneration and diabetic retinopathy, including diabetic macular edema. Through its innovative approach, Drive Therapeutics aims to provide more effective solutions for patients suffering from these serious eye conditions.
Kinetica Labs is a company based in Ann Arbor, Michigan, specializing in sensing and simulation technology. It provides innovative Motion Capture technology that transforms video footage into precise posture data, enabling the assessment of ergonomic risks in the workplace without relying on markers, suits, or sensors. In addition to its core technology, Kinetica Labs offers a range of services including insurance consultancy, safety audits, ergonomic assessments, and physical therapy services, catering to clients seeking to enhance workplace safety and employee well-being.
Developer of recombinant protein-based materials designed to mimic those naturally found in this environment. The company's products have core protein biometrics composed of a simple modular design, translated into a system that forms fractal-like porous networks with material properties after injection and exposure to body heat, enabling medical researchers to get the required bio-compatible materials used in tissue engineering and regenerative medicine.
Cordance Medical is a medical device company focused on developing innovative therapies for central nervous system (CNS) pathologies, including primary and metastatic cancers, Alzheimer's disease, and Parkinson's disease. The company has created a non-invasive ultrasound system that precisely opens the blood-brain barrier, allowing for targeted delivery of systemically administered drugs to specific brain regions. This low-power ultrasound technology aims to enhance diagnostic and therapeutic options for patients, providing a safe and effective means to address complex neurological conditions.
Operator of a digital health platform intended to make a clinical encounter productive by improving patient-doctor communication. The company's platform is advantageous for public health providers that serve a disproportionately high number of patients who do not speak English and improves access to care for people with communication barriers, enabling disadvantaged patients to accurately and remotely self-report symptoms that are often missed.
Desert Valley Tech, founded in 2018 and based in Mesa, Arizona, specializes in developing cold chain storage systems designed to preserve temperature-sensitive items such as blood, pharmaceuticals, biologics, and organs. The company's innovative system maintains pre-set temperatures while optimizing power consumption, providing customizable modular storage solutions suited for various scenarios. This technology enhances the ability of medical professionals to ensure the safe transport and storage of critical medical supplies, ultimately improving survival rates in challenging and remote medical environments.
Operator of a life science platform intended for democratizing advanced single-cell assays. The company's novel nano vial platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological functions such as secreted proteins, enabling biotech labs and clients to develop higher-performing therapies for cancer, autoimmune conditions, and infectious diseases.
Gate Scientific makes products that enable great research and improve healthcare decisions by bringing to market intuitive solutions that simplify complex problems. By bringing to market intuitive solutions that simplify complex problems, they allow for the latest technologies to benefit more people.
Lisa Health is a digital platform for menopause and midlife women's health. Menopause is a transition every woman around the globe will experience. Eighty-five percent will have symptoms that adversely impact their health, quality of life, relationships, and productivity at work. Lisa Health manages the menopause journey and midlife wellbeing with personalized, science-based, community-supported guidance.
Developer of a wearable monitoring device designed for early stroke detection. The company's device accurately detects the onset of hemiparesis which is paralysis on one side of the body using patient-worn wearables and connects users with emergency responders, enabling older citizens living with high stroke risk to prevent disability, live independently, and bring peace of mind to their families.
Notus Labs specializes in developing wearable devices that enable individuals to monitor their health and performance in a remote and non-invasive manner. These devices provide a continuous and comprehensive summary of vital signs, which can help optimize medical triaging during instances of sudden physiological deterioration. By utilizing Notus Labs' technology, users can effectively mitigate the risks associated with overexertion injuries and heat-related illnesses. Additionally, the devices offer training suggestions to enhance physical performance, allowing users to maximize their growth while maintaining safety during physical activities.
Wildlife Protection Management, Inc. manufactures a dart system for delivering vaccines and contraceptives on the horses. Its system also allows for the delivery of radio-frequency identification (RFID) chips for identifying each horse and monitoring the health and location. Wildlife Protection Management, Inc. was incorporated in 2018 and is based in Albuquerque, New Mexico.
Precision Theranostics is a biotechnology company based in Baltimore, Maryland, founded in 2019. The company focuses on developing prognosis-based intervention strategies aimed at the early detection and treatment of fatal diseases. Its innovative platform is designed to estimate disease progression, particularly for respiratory diseases and age-related disorders. By creating novel diagnostics, therapeutics, and prognosis-based therapies, Precision Theranostics enables healthcare providers to deliver timely diagnoses and interventions, ultimately improving survival rates and preventing the progression of chronic and fatal conditions.
CellDrop Biosciences, established in 2017 and based in Laramie, Wyoming, specializes in hydrogel-based technology for point-of-care diagnostics and targeted biomaterial delivery. The company focuses on developing hydrogel platforms that enable precise control over chemical and biological systems. Its innovations aim to facilitate the healing of equine musculoskeletal injuries efficiently, while also minimizing the risk of re-injury. By providing effective diagnostic and treatment solutions, CellDrop Biosciences addresses critical needs within the veterinary medical community.
Radiosight, founded in 2020 and headquartered in Hoboken, New Jersey, specializes in ultra-wide imaging technology aimed at improving the diagnosis of skin cancer and assisting in surgical decisions. The company has developed an innovative technique that enhances image resolutions, offering a handheld 3D imaging device that reveals the underlying shape and profile of suspicious tissue. This technology enables dermatologists to better visualize the margins before biopsy, thereby increasing the accuracy of skin lesion excisions. Through its advanced imaging solutions, Radiosight seeks to enhance the effectiveness of skin cancer treatment and diagnosis.
Grapevine Health is a data-driven health media company focused on improving health literacy among underserved communities. By utilizing technical expertise and trusted communicators, the organization provides culturally appropriate health information that is both relatable and understandable. Their services assist health systems, insurers, and medical providers in enhancing community outreach and engagement, ensuring that health information is accessible and empowering for patients. Through empathetic storytelling and tailored communication strategies, Grapevine Health aims to democratize health information and support the maintenance of healthy behaviors within these communities.
HealthTrends.AI is a trusted third party delivering ongoing authoritative health information that is independently auditable. Our mission is to help organizations turn health data into actionable information. We offer a platform-agnostic solution embedded in our products. Products are available as streaming feeds, APIs, and dashboards enabling flexible integration with 3rd party tools (Power BI, Tableau, etc.). Our tools are designed to be easily accessible and plug into and enhance your existing in-house systems with an intuitive platform.
Manufacturer of surgical devices intended to enhance surgeon performance. The company's system provides critical decision-making information along with superior performance and a smart balance of features and ease the way surgeons approach soft tissue management, enabling surgeons to extend their tactile reach to the target tissue with AI guidance, minimize inefficient workflows, reduce costs, and eliminate toxic waste disposal.
Enable Therapeutics
Grant in 2021
Enable Therapeutics is a biotechnology company developing a patented drug delivery platform. The company was founded in 2020 and is headquartered in Hopedale, Massachusetts.
Developer of life science platform intended to provide accurate methods to test dangerous endotoxins. The company provides advanced healthcare innovations for the detection of blood-borne pathogens, enabling physicians to develop a rapid and sensitive diagnostic for detecting bloodstream infection.
Impact Proteomics, LLC specializes in protein sample preparation, offering a range of kits and reagents designed to produce contaminant-free samples. Founded in 2017 and based in Pittsburgh, Pennsylvania, the company provides various products, including Universal Protein Extraction and Clean Kits for peptides, whole proteins, and immunoprecipitation, as well as Promtag Reversible Protein Tagging Agents and related accessories. By supplying tools for efficient protein handling, Impact Proteomics aims to enhance drug and biomarker discovery processes, allowing researchers to accelerate the development of therapeutics and diagnostics. The company's offerings are available for purchase online, reflecting its commitment to supporting the scientific community in advancing medical research.
Abram’s is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders, delivering rapid hemostasis information to improve clinical outcomes.
New Horizon Biotech specializes in biotechnology and biopharmaceutical products, focusing on optimizing supply chains and ensuring consistent quality globally at a reduced cost. The company is finalizing tests of its patented Single Use Horizontal Fermentor system (SUHF™), which is designed for single-use microbial fermentation. This innovative system is set to enhance production efficiencies and operational cost savings, offering significant advantages over traditional fermentor designs. By improving the microbial fermentation process, New Horizon Biotech aims to support the production of high-value biopharmaceuticals, including antibiotics, vaccines, and therapeutic proteins, thereby strengthening the global competitive edge of its clients.
NeyroblastGX is a biotechnology company established in 2020 and based in Murrieta, California, focused on developing theranostic products aimed at treating neurodegenerative and infectious diseases. The company’s product offerings include a blood-based biomarker diagnostic for Alzheimer's, genetically engineered dendritic cells designed to eliminate custom-made human organoids for drug screening, cellular toxicity assessment, and disease pathology. Additionally, NeyroblastGX develops an oral supplement intended to enhance protective immunity, providing patients with a comprehensive portfolio of diagnostics, drugs, and therapies to combat life-threatening conditions.
DPX Technologies, founded in 2007 and based in Columbia, South Carolina, specializes in patented pipette tip technology aimed at enhancing the quality of products used in complex chemical and biological analyses. The company's innovative technology is designed for automated liquid handling systems, offering customizable solutions that simplify and automate intricate sample preparation processes. This enables scientists to efficiently implement automated solutions that can be tailored to various laboratory workflows and methods, thereby improving overall analytical performance in research and development settings.
fluidion™ aims to develop systems for sampling and analysis of water for a number of different markets: water quality in low pressure conditions (rivers, ponds, lakes, coastal waters), and monitoring in deep water (oceanography). fluidion™ pursues a strong R&D program in multiple areas, targeting both national and international development, collaborations and market growth. They continuously develop new tools for automated sampling in difficult environments, for sensitive water quality monitoring, and for high-resolution monitoring of the environment.
Cobio Diagnostics is a biotechnology company that develops diagnostics for bacterial identification and phenotypic antibiotic resistance testing. The company was established in 2016 and is based in Golden, Colorado.
Instapath Inc. specializes in designing and developing a microscopy system that enhances the evaluation of cancer biopsies. The company’s technology allows for imaging biopsy samples at subcellular resolution immediately after removal, while also preserving the tissue for future analysis. This innovation aims to address a critical need, as over 7 million Americans undergo biopsy procedures annually, with a significant portion failing to provide accurate diagnoses, leading to costly repeat procedures. By improving rapid on-site evaluation of biopsies, Instapath’s system reduces the necessity for these repeat procedures, thereby increasing operating room efficiency and potentially boosting hospital revenue. Founded in 2017, Instapath is headquartered in New Orleans, Louisiana.
OmniVis operates a portable pathogen detection platform that allows for the rapid and accurate measurement of pathogens in various environments, particularly in food processing facilities. The company provides an easy-to-use hardware device in conjunction with disposable test kits that can analyze swabs or liquid samples. This streamlined process reduces the pathogen detection time to just 30 minutes, making it both efficient and cost-effective for health organizations. By focusing on user-friendly technology, OmniVis aims to enhance the accuracy of pathogen detection while ensuring affordability and simplicity in its application.
Nanoxort, founded in 2018 and based in Auburn, Alabama, specializes in developing diffusive magnetic fractionation (DMF) technology that allows precise control over the properties of magnetic nanomaterials. This innovative technology is particularly significant in the healthcare sector, as it enhances contrast agent injections for patients undergoing MRI scans. By improving image resolution, Nanoxort's technology reduces the toxic effects associated with traditional MRI contrast agents, particularly gadolinium, which poses risks for individuals with compromised kidney function. Consequently, Nanoxort's advancements contribute to safer imaging practices, minimizing gadolinium exposure for patients who require frequent MRI procedures.
CytoRecovery, Inc. is a company specializing in the development of microfluidic technology aimed at recovering and analyzing subpopulations of cancer cells from tumor biopsies and other biological samples. Founded in 2017 and headquartered in Blacksburg, Virginia, CytoRecovery's innovative technology allows cell biologists and life science researchers to efficiently select and retrieve rare, homogeneous, and viable cell subpopulations from tissues and blood. The technology facilitates individual trapping and release of these rare cells, enabling more effective downstream analysis and enhancing research capabilities in cancer biology and related fields.
VeriSIM Life, Inc. develops disease-specific biosimulation models that allow researchers at pharmaceutical companies to model in software how a drug will interact in animals. The company was incorporated in 2017 and is based in San Francisco, California.
PediaMetrix Inc. develops a smart digital tool for pediatric head measurement and monitoring. It offers a flat head syndrome app enables parents to receive accurate measures of their baby's head shape and receive repositioning instructions specific to their baby instantly. The company’s app also enables pediatricians to have access to the data and easy-to-understand analysis of the smart algorithms behind the app to save time and ensure quality care. PediaMetrix Inc. was founded in 2018 and is based in Rockville, Maryland.
Spatio Metrics presents architecture as a new tool for advancing health by filling the gap between design, data, and performance. The company helps hospitals manage facilities with a dashboard that shows how spaces influences patients’ health outcomes. The company's product analyzes floor plans, reveals design gaps, and recommends performance improvements. Hospital administrators are encouraged to make smarter design investments by quantifying the human and financial impact of design.
Active Therapy Systems is a company based in Nicholasville, Kentucky, founded in 2017. It specializes in developing an interactive exercise platform designed to provide in-home therapies for individuals living with Parkinson's disease. The platform aims to enhance the management of Parkinson's through personalized therapies and remote patient monitoring, allowing users to engage in activities that may help alleviate their symptoms. By focusing on the specific needs of those affected by Parkinson's, Active Therapy Systems seeks to improve their quality of life and promote greater independence in daily activities.
Gradient Medical develops novel interventional oncology services to bring ACE therapy to the clinic. The company was founded in 2020 and is headquartered in Raleigh, North Carolina.
Operator of a biotechnology company intended to improve research, health, and wellness by providing access to accurate and cost-effective specimen collection devices. The company's device stabilized sensitive tests and facilitates remote specimen collection, including urine, serum, plasma, or any other bodily fluid, and simple transportation at ambient temperature, enabling people in the community to access accurate and cost-effective diagnoses.
CasTag Biosciences specializes in cell biology and regenerative medicine, focusing on revolutionizing the speed of endogenously protein analysis. The company aims to accelerate scientific discovery by offering tools that allow scientists to study novel genes in any experimental model.
Vena Vitals makes a small sticker that monitors blood pressure continuously. Vena Vitals showed that it works in the operating room and is as accurate as the best tools doctors have today, at a fraction of the cost. We're a team of health tech scientists with multiple past startups and exits, and we've built products that have scaled to over 2M users.
Manufacturer of microscopy toolset intended to capture cellular-level detail over hundreds of square centimeters. The company's microscope uses custom-designed control electronics to deliver and process massive amounts of image data from a large array of micro-cameras, enabling companies to capture, analyze, and securely store tens of gigapixels of object-specific data with high throughput and improved analysis.
Progenitor MDX provides a comprehensive and customizable solution to manage COVID-19 infections from start to finish. We not only deliver testing results, but also help you develop actionable plans for infection management, providing reassurance to your communities.
O2M Technologies develops oxygen imaging devices for effective cancer and regenerative medicine treatments. The company was founded in 2017 and is headquartered in Chicago, Illinois.
BioAesthetics Corporation, founded in 2015 as a spin-out from Tulane University, specializes in developing innovative reconstruction solutions for breast cancer patients who have undergone mastectomies. The company's primary product is a tissue-engineered nipple-areolar complex (NAC), designed to facilitate the regeneration of the nipple and areola during the breast reconstruction phase. This biologically derived graft serves as an acellular, off-the-shelf option for plastic and reconstructive surgeons, allowing the patient's own cells to integrate and restore the NAC. Currently in the pre-clinical phase, this patent-pending technology aims to improve surgical outcomes and enhance the quality of life for patients with incomplete or removed NACs due to disease, surgery, or birth defects. BioAesthetics is headquartered in Research Triangle Park, North Carolina.
BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.
Creative BioTherapeutics is a biotechnology company developing therapies for cancer and viruses. The company is changing the way that cancer and viral disease research is conducted. It focuses on the root cause of cancer affecting immune evasion and drug resistance.
RadWave Technologies Inc. is an early-stage company based in Saint Paul, Minnesota, that specializes in developing advanced technologies for minimally invasive medical procedures. Founded in 2018, the company has created an electromagnetic navigation system that enhances the accuracy of object tracking during complex surgical operations. This innovative system provides performance tracking services for image-guided, minimally invasive, and robotic procedures, allowing medical professionals to effectively locate surgical instruments and tools within the human body, even in scenarios where there is no direct line of sight. Through its cutting-edge technology, RadWave Technologies aims to improve surgical outcomes and enhance the capabilities of healthcare providers.
Lasarrus is a Baltimore-based company founded in 2013 that specializes in developing wearable devices for patients with chronic obstructive pulmonary disease (COPD). The company's innovative device is designed to enhance physical therapy by facilitating telemedicine and remote monitoring. It captures physiological and range-of-motion data, allowing patients to track their health routines effectively. Lasarrus aims to provide an affordable, comfortable, and non-invasive solution that accelerates recovery for users, improving their overall health management.
Developer of a medical technology designed to offer treatment for heart failure. The company's technology specializes in offering advanced transcatheter heart valve therapies, enabling patients to prevent structural heart failure.
Inanovate Inc. is a company that specializes in developing protein screening and analysis products tailored for the life sciences sector. Its flagship offering, the Bio-ID platform, is a protein screening biochip that provides sensitive and real-time kinetic data on multiple protein interactions. This technology supports a variety of applications, including protein research, drug development, quality control, biomarker profiling, and clinical diagnostics. Inanovate also engages in biomarker alliance programs that focus on biomarker discovery and validation, and it utilizes i-Slide technology for protein immobilization on biochip surfaces. The company offers a range of protein micro-array services, including protein printing and assay development. Established in 2005 and headquartered in Sioux Falls, South Dakota, with an additional office in Raleigh, North Carolina, Inanovate serves researchers, clinical centers, and biotech and pharmaceutical companies across the United States and the United Kingdom.
NanoInnovations is a research and development company based in Sugar Land, Texas, founded in 2014. The firm specializes in the commercialization of smart nanosensors integrated with machine learning technology for healthcare analytics. Its innovative platform utilizes bio-fluids, including sweat and saliva, to provide critical insights related to conditions such as diabetes and heart failure. By delivering real-time information, NanoInnovations aims to enhance patient care and improve healthcare management practices, empowering clients to make informed decisions in a timely manner.